EUSA Pharma said the European Commission approved the antibody ch14.18/CHO, dinutuximab beta, to treat children at least 1-year-old affected by neuroblastoma, a form of childhood cancer.

Merck said the European Commission has approved the use of its Keytruda to treat adult patients with Hodgkin's lymphoma in some instances, allowing the company to market the drug throughout the European Union and in Iceland, Lichtenstein and Norway at an approved dose of 200 milligrams every three weeks with doctor supervision.

The National Institute on Alcohol Abuse and Alcoholism, a part of the National Institutes of Health (NIH), has released its five-year strategic plan for research to optimize the allocation of resources as the NIAAA works to understand and treat alcohol-related diseases.

The American Academy of Family Physicians (AAFP) has endorsed new osteoporosis treatment guidelines issued by the American College of Physicians (ACP).

Nautilus Medical said it is working to put radiology images and reports into patients' hands quickly and reduce the overhead for health care providers.

May is Lupus Awareness Month, and the Lupus Foundation of America is working to help the disease become more understood by the American public.

Genetic engineering will soon make commercial blue jean production cheaper than ever, according to Dr. Henry Miller, a founding director for the Food and Drug Administration's Office of Biotechnology and research fellow at Stanford University’s Hoover Institution.

Utah and Louisiana have joined the growing list of states that have taken steps to reduce deaths from opioid overdose.

Legislation to help children suffering from cancer was introduced in Congress by members of both the Democratic and Republican parties recently. The legislation, known as the Childhood Cancer Survivorship, Treatment, Access and Research Act (STAR), is intended to increase the development and availability of promising cancer treatments.

Recent research indicates that stem cell transplants might provide a long-awaited breakthrough for people suffering from multiple sclerosis (MS), a disease in which the central nervous system is attacked by the body's immune system, often causing chronic pain, difficulties speaking, weakness and fatigue, among other symptoms.

An anecdotal story about the rock band Van Halen recently became a teaching  opportunity for geriatrician Andrea Wershof Schwartz.

A coalition of health care organizations has banded together to call for reforms of prior authorization requirements.

The doctor-patient relationship and the role of medical professionals as a trusted place for victims to seek help is the subject of a recently published article by the American Association of Family Physicians.

The CEO of the Pharmaceutical Research and Manufacturers of America along with other industry leaders met with President Donald Trump, Vice President Mike Pence and House Energy and Commerce Chairman Greg Walden (R-OR) according to a blog post on the organization’s website.

Cancer is still a leading cause of death in America, but cervical cancer death rates have dropped dramatically in the past 40 years, down more than 50 percent, according to the American Cancer Society.

The American Diabetes Association announced a new website as part of it’s Stand Up for Affordable Insulin Initiative which was launched last November.

Two Texas kids turned a tragedy into an opportunity to help others in times of crisis after they recently found themselves in the ICU waiting area at Medical City McKinney, according to a report by the American Heart Association.

The Lupus Foundation is highlighting the personal experiences and perspectives of those living with the disease, with a new series titled, “Sharing the Journey.”

The number of adults living with heart failure increased by almost a million people according to the American Heart Association in its 2017 Heart Disease and Stroke Statistics Update.

A new final rule issued by the Health Resources and Services Administration puts in place new ceiling pricing and penalty guidelines for drug manufacturers.